OMRX Stock Overview

Develops technologies, procedures, and devices to help increase musculoskeletal mobility, as well as non-invasive technologies to treat the pain associated with osteoarthritis, plantar fasciitis, and other musculoskeletal conditions that reduce mobility. More details

OMRX fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Does not have a meaningful market cap ($5K)

Latest financial reports are more than a year old

Shares are highly illiquid

My Notes

Capture your thoughts, links and company narrative

Orthometrix, Inc. Competitors

Lucira Health

OTCPK:LHDX.Q

US$4.2k

ThermoGenesis Holdings

OTCPK:THMO

US$11.1k

ViewRay

OTCPK:VRAY.Q

US$18.3k

Motus GI Holdings

OTCPK:MOTS

US$719.0

Price History & Performance

Summary of share price highs, lows and changes for Orthometrix
Historical stock prices
Current Share Price	US$0.0001
52 Week High	US$0.0001
52 Week Low	US$0.0001
Beta	0
1 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	0%
5 Year Change	-95.65%
Change since IPO	-100.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	OMRX	US Medical Equipment	US Market
7D	0%	3.7%	3.2%
1Y	n/a	12.3%	24.0%

Return vs Industry: Insufficient data to determine how OMRX performed against the US Medical Equipment industry.

Return vs Market: Insufficient data to determine how OMRX performed against the US Market.

Price Volatility

Is OMRX's price volatile compared to industry and market?
OMRX volatility
OMRX Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	8.7%
Market Average Movement	6.5%
10% most volatile stocks in US Market	18.7%
10% least volatile stocks in US Market	3.2%

Stable Share Price: OMRX has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine OMRX's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1993	n/a	Reynald Bonmati	n/a

Orthometrix, Inc. develops technologies, procedures, and devices to help increase musculoskeletal mobility, as well as non-invasive technologies to treat the pain associated with osteoarthritis, plantar fasciitis, and other musculoskeletal conditions that reduce mobility. The company markets, sells, and services peripheral quantitative computed tomography bone and muscle measurement systems for research and clinical applications; patented motorized exercise systems for rehabilitation, physical therapy, and sports medicine based on patented vibration technology; human performance measurement systems for monitoring improvement in power and mobility; and extracorporeal shock wave therapy systems for non-invasive treatment of pain associated with plantar fasciitis. It also markets, sells, and services patented motorized exercise systems to professional teams, fitness centers, gyms, sports clubs, and wellness-conscious general public.

Orthometrix, Inc. Fundamentals Summary

How do Orthometrix's earnings and revenue compare to its market cap?
OMRX fundamental statistics
Market cap	US$5.32k
Earnings (TTM)	-US$959.26k
Revenue (TTM)	US$1.46m

0.0x

P/S Ratio

0.0x

P/E Ratio

Is OMRX overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
OMRX income statement (TTM)
Revenue	US$1.46m
Cost of Revenue	US$865.69k
Gross Profit	US$591.06k
Other Expenses	US$1.55m
Earnings	-US$959.26k

Last Reported Earnings

Sep 30, 2008

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did OMRX perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/09/10 15:47
End of Day Share Price	2024/06/13 00:00
Earnings	2008/09/30
Annual Earnings	2007/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Orthometrix, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution